On January 20, 2025, Salus Pro, a domestically produced gene sequencer independently developed by Sailu Medical, was approved by the National Medical Products Administration (NMPA) for Class III medical device registration certificate (National Device Approval 20253220191). The product is provided by Jiutai Pharmaceutical and Medical Devices for clinical trial services.

In the first half of February, the Device Review Center of the State Food and Drug Administration released two technical review reports on medical device products. The content is as follows

Looking back on the past year, the medical device CRO industry has broken the waves in the ever-changing market wave, and many companies have bravely stood at the forefront of the tide, taking innovation as the sail and professional oars, and have made remarkable achievements in helping the R&D and upgrading of medical devices and promoting the compliance and listing of products. With perseverance and innovation, Jiutai Pharmaceutical and Medical Devices has helped many medical device products break through many difficulties, successfully move from a blueprint to clinical application, and obtain registration approval, thereby bringing a new dawn to patients around the world. On the occasion of saying goodbye to the old and welcoming the new, as peers in the field of medical device CRO, we are full of enthusiasm and look back on those wonderful moments that we have walked hand in hand.